Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase
Observational
Started
2025-05
Last updated
2025-04-09
Condition(s) studied
Retinal DiseasesChoroidal DiseasePathological MyopiaDiabetic RetinopathyAge Related Macular DegenerationChoroidal Neovascularization
Investigational drug(s) / intervention(s)
With fundus diseasesWithout fundus diseases
With fundus diseases: With fundus diseases
Without fundus diseases: Without fundus diseases
Study summary
To establish a multimodal fundus image report generation model to realize an interpretable system for multiple fundus diseases, multimodal image analysis, diagnosis, and treatment decision automatic reporting based on weakly labeled training data. Construct an interpretable feature fusion network for the clinical and imaging features of fundus lesions, and we hope to extract new imaging markers that can predict the occurrence and progression of various fundus lesions at an early stage, and ultimately verify them in real clinical data, further providing possible directions for exploring the molecular mechanisms of refractory fundus lesions, and may also provide new ideas for the precise prevention and treatment of fundus lesions.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Disease group: All multimodal fundus examination images containing fundus lesions, examined from January 2011 to December 2023, including fundus photography, as well as OCT, OCTA, FFA, ICGA, B-ultrasound and corresponding imaging reports. Images could be either clear or unclear, reports are either complete or incomplete.
* Normal group: All multimodal fundus examination images without fundus lesions, examined from January 2011 to December 2023, including fundus photography, as well as OCT, OCTA, FFA, ICGA, B-ultrasound and corresponding imaging reports. Images could be either clear or unclear, reports are either complete or incomplete.
Exclusion Criteria:
* Disease group: 1. The image has serious quality problems; 2. The diagnostic report lacks key information.
* Normal group: 1. The image has serious quality problems; 2. The diagnostic report lacks key information.
Primary outcome measure(s)
Fundus Fluorescein Angiography (FFA) images with corresponding report — Baseline Fundus Fluorescein Angiography(FFA) images with corresponding report were collected. FFA allows dynamic observation of changes in retinal blood vessels and lesions.
Indocyanine Green Angiography (ICGA) images with report — Baseline Indocyanine Green Angiography (ICGA) images with corresponding report were collected. ICGA allows dynamic observation of changes in choroidal blood vessels and lesions.
Fundus photography with corresponding report — Baseline Fundus photography images with corresponding report were collected. Fundus photography provides observation of morphological manifestations of the retina, the retinal blood vessels, the optic nerve, as well as lesions on the retina.
Optical coherence tomography (OCT) images with corresponding report — Baseline Optical coherence tomography (OCT) images with corresponding report were collected. OCT images provides observation of changes in retinal thickness, morphology and manifestations of lesions in each retinal or choroidal layer, as well as lesions in the macular area and optic nerve
Optical coherence tomography angiography (OCTA) images with corresponding report — Baseline Optical coherence tomography angiography (OCTA) images with corresponding report were collected. OCTA images provides observation of the density, morphology, and manifestations of retinal blood vessels, as well as the morphology and manifestations of retinal lesions
Trial sites (1)
Facility
City
Region
Status
Zhongshan Ophthalmic Center
Guangzhou
Guangdong
More Zhongshan Ophthalmic Center, Sun Yat-sen University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.